Phase 3 clinical trials of higher-dose semaglutide (Wegovy) reported average weight loss of approximately 1415% of starting body weight over 68 weeks
Weight loss is rarely linear, and plateaus are common and normal during treatment
Safety Tips Double-check calculations: Always verify your math before injecting Use consistent syringe size: Stick with the same syringe type to avoid confusion Separate math from protocol decisions: A correct unit conversion does not establish a recommended regimen Label your vials: Mark concentration and reconstitution date Verify clarity: Discard if solution appears cloudy or discolored Understanding Concentrations Concentration is how much peptide is dissolved per ml of liquid
Teperek, M., Simeone, A., Gaggioli, V., Miyamoto, K., Allen, G.E., Erkek, S., Kwon, T., Marcotte, E.M., Zegerman, P
It is also one of the hardest-wearing low-tops weve tested, showing the highest durability results in our Dremel tests